ABCL
AbCellera Biologics Inc. · Healthcare
Thermopylae Holdings Ltd. bought $3.0M of AbCellera Biologics Inc.
10% owner
Bought$2,995,913
$14.76Price
202,960Shares
What ABCL did for a copier
- $1,000 copied at Mon, Nov 15 open, $15.57
- $878
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Dec 29 close.
Thermopylae Holdings Ltd.'s record
7 other buys with 3 months of prices since 2022: on average +39.3% against the S&P 500, and 6 of 7 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Nov 11. Filed Mon, Nov 15, 6:05 AM ET, before the open. Returns use the Nov 15 open and the Dec 29 close. Not investment advice.